PureTech Health (GB:PRTC) has released an update.
PureTech Health has announced that Harvard Professor Raju Kucherlapati, PhD, has been appointed as the permanent Chair of its Board of Directors, succeeding his role as interim Chair. Dr. Kucherlapati’s extensive experience in genetics and medicine, as well as his previous contributions to PureTech’s success, are set to guide the company through its next phase of growth and development. The company recognizes his valuable expertise and leadership as it continues to advance its pipeline of innovative therapeutics for patients with devastating diseases.
For further insights into GB:PRTC stock, check out TipRanks’ Stock Analysis page.
